Convatec GroupLSE:CTEC -0.09%77 Interest Coverage is 6.29 as of Dec. 2025, which is 44% above its 10-year median of 4.37. GuruFocus rates LSE:CTEC with a GF Score™ of 77/100 and a GF Value™ of £2.55 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 468 Medical Devices & Instruments companies, Convatec Group ranks worse than 71.37% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Convatec Group's
Operating Income
for the
six
months ended in Dec. 2025 was £154 Mil. Convatec Group's Interest Expense for the
six
months ended in Dec. 2025 was £-25 Mil.
Convatec Group's interest coverage for the quarter that ended in Dec. 2025 was 6.29.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Convatec Group's Interest Coverage or its related term are showing as below:
LSE:CTEC'
s Interest Coverage Range Over the Past 10 Years
Min: 0.66 Med: 4.37 Max: 6.23
Current: 6.23
LSE:CTEC's Interest Coverage is ranked worse than 71.37% of 468
companies
in the Medical Devices & Instruments industry
Industry Median: 15.71
vs LSE:CTEC: 6.23
Convatec Group (LSE:CTEC) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Convatec Group Interest Coverage Related Terms
Convatec Group Interest Coverage Historical Data
* Premium members only.
The historical data trend for Convatec Group's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
LSE:CTEC vs ISRG, BDX, MDLN: Interest Coverage Comparison
For the Medical Instruments & Supplies subindustry, Convatec Group's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Convatec Group Interest Coverage vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Convatec Group's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Convatec Group's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Convatec Group (LSE:CTEC) has a Interest Coverage of 6.29 as of Dec. 2025. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Convatec Group and its competitors. This is 44% above median its historical median of 4.37. Over the past decade, Convatec Group's Interest Coverage has ranged from 0.66 to 6.23. According to the industry distribution chart, Convatec Group ranks #334 out of 468 companies in the Medical Devices & Instruments industry, placing it in the top 71.4%.
Is Convatec Group's Interest Coverage too high?
Convatec Group's current Interest Coverage of 6.29 is 44% above median its 10-year median of 4.37. Over the past 10 years, this metric has ranged from a low of 0.66 to a high of 6.23. The Medical Devices & Instruments industry median Interest Coverage is 15.71. Convatec Group's value of 6.29 is 60% below this industry median. Based on the distribution chart, Convatec Group ranks #334 out of 468 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Convatec Group has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Convatec Group's Interest Coverage compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Convatec Group ranks #334 out of 468 companies for Interest Coverage. This places Convatec Group in the lower half of its industry. The industry median Interest Coverage is 15.71. Convatec Group's value of 6.29 is 60% below this benchmark. Historically, Convatec Group's own Interest Coverage has ranged from 0.66 to 6.23 over the past decade. While the company's 10-year median is 4.37 vs. the industry median of 15.71, Convatec Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Devices & Instruments company?
The median Interest Coverage among Medical Devices & Instruments companies is 15.71, based on 468 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Convatec Group's current Interest Coverage of 6.29 is 60% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Convatec Group and its competitors. For the Medical Devices & Instruments industry, the median Interest Coverage is 15.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Convatec Group's current Interest Coverage is 6.29, which is 44% above median its own 10-year median of 4.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Convatec Group stock overvalued right now?
Based on GuruFocus' analysis, Convatec Group (LSE:CTEC) is currently considered Modestly Undervalued. The stock's GF Value™ is £2.55, compared to a current price of £2.12 — trading 17% below its estimated fair value. The current Interest Coverage is 6.29, which is 44% above median its 10-year median of 4.37 and 60% below the Medical Devices & Instruments industry median of 15.71. Convatec Group's overall GF Score™ is 77/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Convatec Group (LSE:CTEC), the current Interest Coverage is 6.29 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Convatec Group (LSE:CTEC) Overvalued in 2026?
Based on GuruFocus' analysis, Convatec Group stock appears to be undervalued.
The current stock price of £2.12 is trading 17% below its estimated GF Value™ of £2.55.
GuruFocus considers Convatec Group to be Modestly Undervalued.
Key valuation signals for LSE:CTEC:
Interest Coverage: 6.29 (44% above median its 10-year median of 4.37)
GF Value™: £2.55 vs. price of £2.12 (17% below fair value)
Industry Position: 60% below the Medical Devices & Instruments median (#334 of 468)
No single metric tells the full story. See the LSE:CTEC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Originally spun out of Bristol-Myers Squibb, Convatec designs, manufactures, and markets advanced wound care, ostomy, continence care, and infusion sets for the acute-care hospital and chronic-care home settings. Advanced wound care and ostomy supplies are the largest divisions, accounting for 32% and 28% of total revenue, respectively. Continence care has become a slightly smaller business (22% of revenue) following the decision to exit the acute care market, and infusion sets contribute 18% of consolidated revenue.
77GF Score
Get the complete analysis for LSE:CTEC
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:CTEC has been successfully added to your 
